Viewing Study NCT00130156


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2025-12-31 @ 11:29 PM
Study NCT ID: NCT00130156
Status: COMPLETED
Last Update Posted: 2013-05-14
First Post: 2005-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
Sponsor: Eisai Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: DTR-886-401
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View